[IBS 코로나19 리포트 시즌2] How far have you come to develop an antibody treatment for COVID-19: Dong-A Science
Jeong-Jin Seo “Unlimited supply of corona antibody therapy to domestic manufacturing costs… vaccine development”
Honorary Chairman Seo Jeong-jin’Complete the phase 3 administration of antibody treatment within 3 months… Consider developing vaccines’
[김창수의 e뉴스 브리핑] Celltrion antibody treatment’Rekirona’ started supplying nationwide medical institutions
![[약업신문]Celltrion abandons clinical trials for COVID-19 prophylactic antibody treatment](http://www.yakup.com/data/editor/news/202102/h2novUG8VoA3AfuWJiVLVpg16dc4x.png "[약업신문]Celltrion abandons clinical trials for COVID-19 prophylactic antibody treatment")
![[IBS 코로나19 리포트 시즌2] How far have you come to develop an antibody treatment for COVID-19: Dong-A Science](http://image.dongascience.com/Photo/2021/02/2b221aa699701acb841498e4451794a8.jpg "[IBS 코로나19 리포트 시즌2] How far have you come to develop an antibody treatment for COVID-19: Dong-A Science")
![[김창수의 e뉴스 브리핑] Celltrion antibody treatment’Rekirona’ started supplying nationwide medical institutions](https://www.fetv.co.kr/data/photos/20210207/art_1613548216527_9f705e.jpg "[김창수의 e뉴스 브리핑] Celltrion antibody treatment’Rekirona’ started supplying nationwide medical institutions")
